Article #9026

Order to speed hallucinogen research hailed as ‘threshold moment’ but concerns remain over access and protections

The scene seemed so far-fetched you could be forgiven for thinking you might be hallucinating.

On the weekend in which psychonauts celebrate “Bicycle Day” – the anniversary of the first LSD trip – Donald Trump was in the Oval Office double-checking that he was correctly pronouncing the name of a lesser-known psychedelic, ibogaine, as he signed a landmark executive order to accelerate research into hallucinogens, and to increase access.